Evidence map›Paper›PMID 36507317›Full record

ArticleFrontiers in neuroscience2022

Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition.

Guanglin Liu, Ruiyan Wang, Huan Chen, Ping Wu, Yaning Fu, Kaixin Li, Mingda Liu, Zhihao Shi, Yuan Zhang, Yue Su and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Patterns of e-Cigarette Use and Smoking Cessation Outcomes: Secondary Analysis of a Large Randomised Controlled Trial to Inform Clinical Advice.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Guanglin LiuChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Ruiyan WangChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Huan ChenChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Ping WuNational Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Beijing, China.
Yaning FuChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Kaixin LiChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Mingda LiuChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Zhihao ShiChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Yuan ZhangChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Yue SuChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Lingxiao SongChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Hongwei HouChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Qingyuan HuChina National Tobacco Quality Supervision & Test Center, Zhengzhou, China.
Tobacco Research Institute · CNChina Tobacco · CNHigh Magnetic Field Laboratory · CNNational Institutes for Food and Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tobacco addiction has been largely attributed to nicotine, a component in tobacco leaves and smoke. However, extensive evidence suggests that some non-nicotine components of smoke should not be overlooked when considering tobacco dependence. Yet, their individual effect and synergistic effect on nicotine reinforcement remain poorly understood. The study herein focused on the role of non-nicotine constituents in promoting the effects of nicotine and their independent reinforcing effects. Denicotinized cigarettes were prepared by chemical extracting of cut tobacco, and the cigarette smoke extracts (CSE, used as a proxy for non-nicotine ingredients) were obtained by machine-smoking the cigarettes and DMSO extraction. The compositions of harmful components, nicotine, and other minor alkaloids in both cut tobacco and the CSE of experimental denicotinized cigarettes were examined by GC-MS, and compared with 3R4F reference cigarettes. individually and in synergy with nicotine were determined by conditioned place preference (CPP), dopamine (DA) level detection, the open field test (OFT), and the elevated plus maze (EPM). Finally, the potential enhancement mechanism of non-nicotinic constituents was investigated by nicotine metabolism and monoamine oxidase A (MAOA) activity inhibition in the striatum of mice and human recombinant MAOA. Thenicotine content in smoke from the experimental denicotinized cigarettes (under ISO machine-smoking conditions) was reduced by 95.1% and retained most minor alkaloids, relative to the 3R4F reference cigarettes. It was found that non-nicotine constituents increased acute locomotor activities. This was especially pronounced for DA levels in NAc and CPP scores, decreased the time in center zone. There were no differences in these metrics with DNC group when compared to the NS group. Non-nicotine constituents alone did not show reinforcing effects in CPP or striatum DA levels in mice. However, in the presence of nicotine, non-nicotine constituents further increased the reinforcing effects. Furthermore, non-nicotine constituents may enhance nicotine's reinforcing effects by inhibiting striatum MAOA activity rather than affecting nicotine metabolism or total striatum DA content in mice. These findings expand our knowledge of the effect on smoking reinforcement of non-nicotine constituents found in tobacco products.

Indexed as

conditioned place preferencedenicotinized cigarettedopaminenon-nicotine constituentstobacco addiction

Identifiers

PMID36507317
PMCPMC9729261
OpenAlexW4309912556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.